New hope for High-Risk breast cancer patients: can extra pill stop Cancer's return?
NCT ID NCT07400523
Summary
This study is testing whether adding the drug ribociclib to standard hormone therapy helps prevent breast cancer from coming back in high-risk patients. It's for women whose cancer didn't completely disappear after initial chemotherapy. Researchers will compare the two-drug combination against hormone therapy alone to see which keeps patients cancer-free longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.